What we've found so far suggests that supervised multimodal exercise during chemoradiotherapy may improve leg strength and physical function in people with glioblastoma. The evidence we've reviewed leans toward this possibility, based on the data we currently have.
Our analysis of the available research shows that engaging in supervised exercise while undergoing chemoradiotherapy could lead to better physical outcomes in just six weeks [1]. Specifically, the assertion we examined indicates improvements in leg strength and the ability to move around for individuals with glioblastoma who participate in structured exercise programs during treatment [1]. The data we reviewed includes 31.0 supporting assertions and no studies or claims that refute this effect [1].
We want to be clear: this is what we’ve found so far, not a final conclusion. Our current analysis is based on limited assertions—only one distinct claim has been analyzed, even if it is supported by multiple lines of reasoning or studies. We cannot yet determine how strong or consistent this effect might be across different patients or settings, because we don’t have access to detailed study designs, sample sizes, or outcome measurements.
We also don’t know what type of exercise was most effective, how often it was done, or whether all patients benefited equally. There may be factors we haven’t accounted for, and more data could change how we interpret these findings over time.
For now, what this means is that supervised exercise during treatment might help maintain or even improve physical function in some glioblastoma patients. It’s a promising signal, but not a guaranteed result for everyone.
If you’re undergoing chemoradiotherapy for glioblastoma, talking to your care team about safe ways to stay active could be a reasonable step—especially if mobility and strength are concerns.
2 items of evidenceView full answer